# Zylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention Platform

- Source: PR Newswire M&A
- Published: 2026-11-06T17:40:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/zylox-tonbridge-and-gl-capital-announce-strategic-investment-in-lifetech-scientific-to-build-a-leading-vascular-and-structural-heart-intervention-platform-302932244.html
- Canonical: https://groundlevelnews.com/story/zylox-tonbridge-and-gl-capital-announce-strategic-investment-in-lifete-a38af6/

HANGZHOU, China, Nov. 6, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) ("Zylox-Tonbridge") today announced a strategic investment in LifeTech Scientific Corporation (HKEX: 1302) ("LifeTech"), in partnership with GL Capital, marking a significant step...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._